Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Inventory (2016 - 2025)

Collegium Pharmaceutical has reported Change in Inventory over the past 10 years, most recently at $2.9 million for Q4 2025.

  • Quarterly results put Change in Inventory at $2.9 million for Q4 2025, up 215.74% from a year ago — trailing twelve months through Dec 2025 was $5.4 million (up 138.44% YoY), and the annual figure for FY2025 was $5.4 million, up 138.44%.
  • Change in Inventory for Q4 2025 was $2.9 million at Collegium Pharmaceutical, up from -$96000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for COLL hit a ceiling of $8.1 million in Q3 2023 and a floor of -$18.2 million in Q4 2022.
  • Median Change in Inventory over the past 5 years was -$1.4 million (2023), compared with a mean of -$3.4 million.
  • Biggest five-year swings in Change in Inventory: plummeted 50516.67% in 2022 and later skyrocketed 257.01% in 2025.
  • Collegium Pharmaceutical's Change in Inventory stood at $36000.0 in 2021, then plummeted by 50516.67% to -$18.2 million in 2022, then skyrocketed by 90.12% to -$1.8 million in 2023, then tumbled by 37.87% to -$2.5 million in 2024, then soared by 215.74% to $2.9 million in 2025.
  • The last three reported values for Change in Inventory were $2.9 million (Q4 2025), -$96000.0 (Q3 2025), and $930000.0 (Q2 2025) per Business Quant data.